Vertex recently said the product may deliver more than $100 million in revenue in the 2025 full year. But it's important to keep in mind that Vertex retains 60% of Casgevy profit while CRISPR ...

Satyen K. Bordoloi My first memory of cancer is the younger brother of a classmate. Blood cancer, we whispered between ...

Across sectors, tech majors worldwide blurred the line between experimental and practical, pushing the world into a new phase ...

Now, Musunuru and colleagues are preparing a master clinical protocol to study a CRISPR therapy that's mostly the same as the one they used to treat baby KJ, except they plan to swap out the gene ...

Gene editing has rapidly evolved into a transformative class of technologies that allow scientists to precisely insert, ...

On the roads, motor-vehicle deaths — which spiked during the pandemic — have now fallen for several years in a row: the ...

Two pilot programs would tie Medicare costs and rebates in the U.S. to what’s paid in comparable countries. Elsewhere, AstraZeneca reported a setback and an “off the shelf” cell therapy showed promise ...

The U.S. Department of Commerce announced Monday that Montana State University will be home to a newly established Community Engagement Office for the U.S. Patent and Trademark Office.

Backed by a handful of prominent investors including the Gates Foundation, the startup is pursuing an approach it believes ...

We're living in a moment where science fiction is becoming medical reality. Imagine a world where doctors can simply rewrite ...

He was cast as a real-life Dr Frankenstein, a scientist whose ego had led him to tamper with human life. After more than a hundred Chinese scientists issued a statement condemning his experiment, ...

Healthcare stocks as a group have not performed on par with broader equities this year. However, that doesn't mean investors ...